These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27612346)

  • 21. Integration of GC/EI-MS and GC/NCI-MS for simultaneous quantitative determination of opiates, amphetamines, MDMA, ketamine, and metabolites in human hair.
    Wu YH; Lin KL; Chen SC; Chang YZ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):192-202. PubMed ID: 18585989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positive ethyl glucuronide immunoassay screening associated with chloral hydrate medication as confirmed by LC-MS/MS and self-medication.
    Arndt T; Gierten B; Güssregen B; Werle A; Grüner J
    Forensic Sci Int; 2009 Jan; 184(1-3):e27-9. PubMed ID: 19084359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphetamines and 3,4-methylendioxymetamphetamine (MDMA): evaluation of KIMS (kinetic interaction of microparticles in solution) assay at two cut-off levels.
    Marchioro L; Bassetto F; Dall'Olio G; Tedeschi L; Castagna F; Plebani M
    Clin Chem Lab Med; 2004 May; 42(5):543-8. PubMed ID: 15202792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fatality due to the use of a designer drug MDMA (Ecstasy).
    Kłys M; Rojek S; Woźniak K; Rzepecka-Woźniak E
    Leg Med (Tokyo); 2007 Jul; 9(4):185-91. PubMed ID: 17320458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of amphetamine, methamphetamine, MDA and MDMA in human hair by GC-EI-MS after derivatization with perfluorooctanoyl chloride.
    Johansen SS; Jornil J
    Scand J Clin Lab Invest; 2009; 69(1):113-20. PubMed ID: 18942018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid, simple, and highly sensitive analysis of drugs in biological samples using thin-layer chromatography coupled with matrix-assisted laser desorption/ionization mass spectrometry.
    Kuwayama K; Tsujikawa K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
    Anal Bioanal Chem; 2012 Jan; 402(3):1257-67. PubMed ID: 22147272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-phase extraction for profiling of ecstasy tablets.
    Rashed AM; Anderson RA; King LA
    J Forensic Sci; 2000 Mar; 45(2):413-7. PubMed ID: 10782963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hair analysis: self-reported use of "speed" and "ecstasy" compared with laboratory findings.
    Cooper GA; Allen DL; Scott KS; Oliver JS; Ditton J; Smith ID
    J Forensic Sci; 2000 Mar; 45(2):400-6. PubMed ID: 10782961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecularly imprinted-solid phase extraction combined with simultaneous derivatization and dispersive liquid-liquid microextraction for selective extraction and preconcentration of methamphetamine and ecstasy from urine samples followed by gas chromatography.
    Djozan D; Farajzadeh MA; Sorouraddin SM; Baheri T
    J Chromatogr A; 2012 Jul; 1248():24-31. PubMed ID: 22704883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of N-tert-butoxycarbonyl-MDMA: a new MDMA precursor.
    Collins M; Donnelly C; Cameron S; Tahtouh M; Salouros H
    Drug Test Anal; 2017 Mar; 9(3):399-404. PubMed ID: 27574107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tetracaine from urethral ointment causes false positive amphetamine results by immunoassay.
    Wijngaard R; Parra-Robert M; Marés L; Escalante A; Salgado E; González-de-la-Presa B; To-Figueras J; Brunet M
    Clin Toxicol (Phila); 2021 Jun; 59(6):500-505. PubMed ID: 33112680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories.
    Skrinska VA; Gock SB
    Clin Lab Sci; 2005; 18(2):119-23. PubMed ID: 15916245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of 3,4-methylenedioxymethamphetamine and its five main metabolites in rat urine by solid-phase extraction and high performance liquid chromatography with on line mass spectrometry.
    Menet MC; Fonsart J; Hervé F; Fompeydie D; Galliot-Guilley M; Noble F; Scherrmann JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2905-10. PubMed ID: 20843750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variability amongst urine toxicology amphetamine readings with concurrent administration of fenofibrate.
    Dadlani N; Farrar A; Jones G
    Australas Psychiatry; 2018 Feb; 26(1):24-26. PubMed ID: 28699773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple and rapid method for determining procetofenic acid, an active metabolite of procetofen, in biological fluids by solid-phase extraction and high-performance liquid chromatography.
    Ramusino AC; Carozzi A
    J Chromatogr; 1986 Dec; 383(2):419-24. PubMed ID: 3558572
    [No Abstract]   [Full Text] [Related]  

  • 37. False-positive urine screen test for MDMA in a patient exposed to mebeverine.
    Bedussi F; Acerbis E; Noseda R; Demagistri D; Zamprogno E; Ceschi A
    Br J Clin Pharmacol; 2021 May; 87(5):2397-2398. PubMed ID: 33200465
    [No Abstract]   [Full Text] [Related]  

  • 38. Lack of a genetic polymorphism in the glucuronidation of fenofibric acid.
    Vincent-Viry M; Cossy C; Galteau MM; Gueguen R; Magdalou J; Nicolas A; Leroy P; Siest G
    Pharmacogenetics; 1995 Feb; 5(1):50-2. PubMed ID: 7773303
    [No Abstract]   [Full Text] [Related]  

  • 39. A Cross-Reactivity of Fenofibric Acid With MDMA DRI Assay.
    Bugier S; Garcia-Hejl C; Vest P; Plantamura J; Chianea D; Renard C
    Mil Med; 2016 Sep; 181(9):1013-5. PubMed ID: 27612346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. False-positive amphetamine/ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (CEDIA) and ecstasy (MDMA/3,4-methylenedioxymethamphetamine) (DRI) test results with fenofibrate.
    Kaplan YC; Erol A; Karadaş B
    Ther Drug Monit; 2012 Oct; 34(5):493-5. PubMed ID: 22972534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.